Lincoln Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 1,464.49 million compared to INR 1,337.66 million a year ago. Revenue was INR 1,574.67 million compared to INR 1,401.24 million a year ago. Net income was INR 280.4 million compared to INR 216.12 million a year ago. Basic earnings per share from continuing operations was INR 14 compared to INR 10.79 a year ago. Diluted earnings per share from continuing operations was INR 14 compared to INR 10.79 a year ago.
For the nine months, sales was INR 4,380.57 million compared to INR 3,978.49 million a year ago. Revenue was INR 4,654.6 million compared to INR 4,164.23 million a year ago. Net income was INR 747.08 million compared to INR 603.38 million a year ago. Basic earnings per share from continuing operations was INR 37.3 compared to INR 30.12 a year ago. Diluted earnings per share from continuing operations was INR 37.3 compared to INR 30.12 a year ago.